Vicapsys Life Sciences annual shares outstanding
2019
2020
2021
2022
2023
Vicapsys Life Sciences Shares Outstanding History (VICP)
Vicapsys Life Sciences reported 32.1M shares outstanding at the end of fiscal 2023.
View full Vicapsys Life Sciences company overviewVicapsys Life Sciences annual shares outstanding history
| Fiscal year | Period ended | Shares outstanding | Change | Growth |
|---|---|---|---|---|
| 2023 | 2023-12-31 | 32.1M | 882,839 | +2.83% |
| 2022 | 2022-12-31 | 31.2M | 11.4M | +57.94% |
| 2021 | 2021-12-31 | 19.7M | 2.3M | +12.95% |
| 2020 | 2020-12-31 | 17.5M | 0 | 0.00% |
| 2019 | 2019-12-31 | 17.5M | — | — |
Vicapsys Life Sciences quarterly shares outstanding
Q4.19
Q1.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q2.24
Q3.24
| Fiscal quarter | Period ended | Shares outstanding | Change | YoY change |
|---|---|---|---|---|
| Q3 2024 | 2024-09-30 | 32.4M | 1.2M | +3.79% |
| Q2 2024 | 2024-06-30 | 32.1M | 882,839 | +2.83% |
| Q4 2023 | 2023-12-31 | 32.1M | 882,839 | +2.83% |
| Q3 2023 | 2023-09-30 | 32.1M | 882,839 | +2.83% |
| Q2 2023 | 2023-06-30 | 31.2M | 0 | 0.00% |
| Q1 2023 | 2023-03-31 | 31.2M | 0 | 0.00% |
| Q4 2022 | 2022-12-31 | 31.2M | 11.4M | +57.94% |
| Q3 2022 | 2022-09-30 | 31.2M | 13.7M | +78.15% |
| Q2 2022 | 2022-06-30 | 31.2M | 13.7M | +78.15% |
| Q1 2022 | 2022-03-31 | 31.2M | 13.7M | +78.15% |
| Q4 2021 | 2021-12-31 | 19.7M | 2.3M | +12.95% |
| Q3 2021 | 2021-09-30 | 17.5M | 24,000 | +0.14% |
| Q2 2021 | 2021-06-30 | 17.5M | 24,000 | +0.14% |
| Q1 2021 | 2021-03-31 | 17.5M | — | — |
| Q4 2020 | 2020-12-31 | 17.5M | — | — |
| Q1 2020 | 2020-03-31 | 17.5M | — | — |
| Q4 2019 | 2019-12-31 | 17.5M | — | — |
Vicapsys Life Sciences shares outstanding trends
Across the available reported history, Vicapsys Life Sciences's shares outstanding moved from 31.2M to 32.1M, a change of 882,839. The latest reported quarter, Q3 2024, shows 32.4M.
About the metric
What shares outstanding means
Shares outstanding is the number of common shares held by investors at a reporting-period end. The count can change because of stock issuance, repurchases, conversions, acquisitions, or stock splits.
Calculation and source
SEC-reported period-end shares
TickerStat displays period-end common shares from SEC filings and adjusts older values to the current share basis when SEC-reported stock-split conversion ratios are available. Values remain as reported when no split ratio is available. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Vicapsys Life Sciences filings at SEC.gov ↗